Abstract Background: Lennox-Gastaut syndrome (LGS) is a severe encephalopathic disease that leads to a decrease in the quality of life,…
Abstract Background: Lennox-Gastaut syndrome (LGS) and Dravet syndrome (DS) are severe, treatment-refractory, epileptic encephalopathies that often develop in infancy or…
Abstract Retrospective chart review of CBD use in patients with LGS and DS in a UK EAP. CBD retention for…
Abstract Background and Purpose: Data regarding the effects of cannabidiol (CBD) on the quality of life (QOL) are currently inadequate.…
Abstract Background: Purified cannabidiol (CBD) was administered to highly refractory patients with Dravet (DS) or Lennox–Gastaut (LGS) syndromes in an…
Abstract Epilepsy, although common, remains difficult to treat with as much as 30% of patients having treatment-resistant conditions. Lennox-Gastaut syndrome…
Abstract Cannabinoids have been found to be effective in controlling seizures and the highly purified form of cannabinoid derived for…
Abstract Objectives: There is an increasing interest in cannabinoid-based products for the treatment of refractory pediatric epilepsy. However, a licensed…
Abstract Lennox-Gastaut syndrome is a severe, childhood-onset electroclinical syndrome comprised of multiple seizure types, intellectual and behavioral disturbances and characteristic…